• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Cannabis Stock Movers For March 6, 2024

    3/6/24 4:30:06 PM ET
    $ACB
    $NEPT
    $PMD
    $YCBD
    Medicinal Chemicals and Botanical Products
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ACB alert in real time by email

    GAINERS:

    • Item 9 Labs (OTC:INLB) shares closed up 33.33% at $0.0004
    • Affinor Growers (OTC:RSSFF) shares closed up 18.44% at $0.05
    • Rocky Mountain High (OTC:RMHB) shares closed up 12.50% at $0.01
    • SOL Glb Inv (OTC:SOLCF) shares closed up 11.30% at $0.07
    • CLS Holdings USA (OTC:CLSH) shares closed up 10.00% at $0.06
    • Pharmadrug (OTC:LMLLF) shares closed up 10.00% at $0.04
    • Body and Mind (OTC:BMMJ) shares closed up 7.69% at $0.07
    • Global Compliance (OTC:FUAPF) shares closed up 7.36% at $0.01
    • Heritage Cannabis Holding (OTC:HERTF) shares closed up 7.35% at $0.01
    • Zoned Props (OTC:ZDPY) shares closed up 5.88% at $0.54
    • Psychemedics (NASDAQ:PMD) shares closed up 5.25% at $3.21
    • EnWave (OTC:NWVCF) shares closed up 4.93% at $0.22
    • cbdMD (AMEX:YCBD) shares closed up 4.77% at $0.72
    • Aurora Cannabis (NASDAQ:ACB) shares closed up 3.39% at $3.00

    LOSERS:

    • AusCann Group Holdings (OTC:ACNNF) shares closed down 95.00% at $0.00
    • Elixinol Wellness (OTC:ELLXF) shares closed down 49.40% at $0.01
    • Neptune Wellness Solns (NASDAQ:NEPT) shares closed down 48.65% at $0.19
    • CordovaCann (OTC:LVRLF) shares closed down 26.11% at $0.07
    • 1933 Industries (OTC:TGIFF) shares closed down 15.38% at $0.01
    • Maple Leaf Green World (OTC:MGWFF) shares closed down 15.27% at $0.03
    • RIV Capital (OTC:CNPOF) shares closed down 9.12% at $0.08
    • Cansortium (OTC:CNTMF) shares closed down 7.79% at $0.18
    • Cresco Labs (OTC:CRLBF) shares closed down 7.10% at $1.57
    • Curaleaf Holdings (OTC:CURLF) shares closed down 7.04% at $4.36
    • MariMed (OTC:MRMD) shares closed down 6.61% at $0.24
    • Green Thumb Industries (OTC:GTBIF) shares closed down 6.46% at $11.97
    • Blueberries Medical (OTC:BBRRF) shares closed down 6.25% at $0.01
    • C21 Investments (OTC:CXXIF) shares closed down 5.30% at $0.34
    • Kaya Holdings (OTC:KAYS) shares closed down 5.00% at $0.04
    • iAnthus Capital Hldgs (OTC:ITHUF) shares closed down 4.50% at $0.02
    • Indiva (OTC:NDVAF) shares closed down 4.32% at $0.07
    • CV Sciences (OTC:CVSI) shares closed down 3.37% at $0.03

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $ACB alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACB
    $NEPT
    $PMD
    $YCBD

    CompanyDatePrice TargetRatingAnalyst
    Aurora Cannabis Inc.
    $ACB
    1/27/2026Buy
    Canaccord Genuity
    Aurora Cannabis Inc.
    $ACB
    12/11/2024Buy
    TD Cowen
    Aurora Cannabis Inc.
    $ACB
    2/9/2024Hold → Buy
    Canaccord Genuity
    Aurora Cannabis Inc.
    $ACB
    9/21/2022Sell → Hold
    Canaccord Genuity
    Aurora Cannabis Inc.
    $ACB
    6/24/2022Neutral → Overweight
    Cantor Fitzgerald
    Aurora Cannabis Inc.
    $ACB
    6/6/2022Sell → Hold
    Stifel
    Aurora Cannabis Inc.
    $ACB
    11/10/2021$9.60 → $10.75Neutral
    Cantor Fitzgerald
    Aurora Cannabis Inc.
    $ACB
    10/28/2021$9.50 → $9.60Neutral
    Cantor Fitzgerald
    More analyst ratings

    $ACB
    $NEPT
    $PMD
    $YCBD
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Powell Anderson Capital Partners Llc bought $305,439 worth of shares (159,700 units at $1.91) (SEC Form 4)

    4 - PSYCHEMEDICS CORP (0000806517) (Issuer)

    12/17/24 8:29:49 PM ET
    $PMD
    Medical Specialities
    Health Care

    Large owner Powell Anderson Capital Partners Llc bought $231,849 worth of shares (86,991 units at $2.67) (SEC Form 4)

    4 - PSYCHEMEDICS CORP (0000806517) (Issuer)

    12/12/24 8:41:51 PM ET
    $PMD
    Medical Specialities
    Health Care

    Director Kamin Peter bought $3,312,823 worth of shares (1,409,712 units at $2.35) (SEC Form 4)

    4 - PSYCHEMEDICS CORP (0000806517) (Issuer)

    12/5/24 6:05:08 PM ET
    $PMD
    Medical Specialities
    Health Care

    $ACB
    $NEPT
    $PMD
    $YCBD
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Crosnoe Clark R. sold $1,276,842 worth of shares (550,701 units at $2.32) (SEC Form 4)

    4 - cbdMD, Inc. (0001644903) (Issuer)

    12/19/25 9:16:26 AM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    CEO and CFO Kennedy Thomas Ronan was granted 445,000 shares, increasing direct ownership by 648% to 513,722 units (SEC Form 4)

    4 - cbdMD, Inc. (0001644903) (Issuer)

    12/2/25 6:29:31 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    Director Porter Jeffrey H was granted 1,572 shares (SEC Form 4)

    4 - cbdMD, Inc. (0001644903) (Issuer)

    5/20/25 5:23:40 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary

    $ACB
    $NEPT
    $PMD
    $YCBD
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand

    NASDAQ | TSX: ACB Launch reinforces Aurora's leadership position across key international markets  EDMONTON, AB, Feb. 11, 2026 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is expanding its Aurora® medical portfolio in Australia and New Zealand, delivering patients and prescribers enhanced choice, reliable quality, and easier access to science-backed products. The expansion underscores the company's ongoing dedication to meeting the unique needs of patients and healthcare professionals in the region, reflecting Aurora's strategic focus on long-term global growth.

    2/11/26 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Cannabis Announces Filing of Prospectus Supplement for At-The-Market Offering Program

    NASDAQ | TSX: ACB EDMONTON, AB, Feb. 4, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has filed a prospectus supplement establishing a new at-the-market offering program (the "ATM Program") that allows the Company to issue and sell up to U.S.$100 million of common shares in the capital of the Company (the "Common Shares") from treasury to the public, from time to time, at the Company's discretion. The Company intends to use the net proceeds from th

    2/4/26 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Cannabis Announces Fiscal 2026 Third Quarter Results

    NASDAQ | TSX: ACB Expands YoY Total Net Revenue1 by 7% to $94.2 million, with Global Medical Cannabis Net Revenue1 Increasing by 12% to a Record $76.2 millionDelivers Adjusted EBITDA1 of $18.5 million and Adjusted Net Income1 of $7.2 millionGenerates Free Cash Flow1 of $15.5 million Maintains Strong Balance Sheet with $154.4 million of Cash2 and Short-Term Investments, and a Debt-Free Cannabis Business2EDMONTON, AB, Feb. 4, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter 2026 period ending December 31, 2025.

    2/4/26 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $NEPT
    $PMD
    $YCBD
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Canaccord Genuity initiated coverage on Aurora Cannabis

    Canaccord Genuity initiated coverage of Aurora Cannabis with a rating of Buy

    1/27/26 9:29:20 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    TD Cowen initiated coverage on Aurora Cannabis

    TD Cowen initiated coverage of Aurora Cannabis with a rating of Buy

    12/11/24 10:35:16 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Cannabis upgraded by Canaccord Genuity

    Canaccord Genuity upgraded Aurora Cannabis from Hold to Buy

    2/9/24 6:09:16 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $NEPT
    $PMD
    $YCBD
    SEC Filings

    View All

    SEC Form 6-K filed by Aurora Cannabis Inc.

    6-K - AURORA CANNABIS INC (0001683541) (Filer)

    2/4/26 4:44:28 PM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Aurora Cannabis Inc.

    6-K - AURORA CANNABIS INC (0001683541) (Filer)

    2/4/26 9:45:22 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    SEC Form 6-K filed by Aurora Cannabis Inc.

    6-K - AURORA CANNABIS INC (0001683541) (Filer)

    2/4/26 7:27:19 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $NEPT
    $PMD
    $YCBD
    Leadership Updates

    Live Leadership Updates

    View All

    Aurora Names Seasoned Global CPG Executive to Lead Australia and New Zealand

    NASDAQ | TSX: ACB EDMONTON, AB, Dec. 8, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces Kerry Miller, a 35-year consumer packaged goods executive, as Managing Director for Australia and New Zealand, effective January 15, 2026. Kerry will be instrumental in driving growth in these key markets, drawing on decades of global experience in fast moving, regulated industries. "I'm excited to join Aurora at an inflection point in the company's global leadership and to work alongside a team dedicated

    12/8/25 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Announces Distribution Partnership with Leafio Australia

    The collaboration will improve medical cannabis access and better serve patients across Australia NASDAQ | TSX: ACB EDMONTON, AB, Dec. 2, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, today announced the company's wholly owned subsidiary, MedReleaf Australia, has entered into a distribution partnership with Leafio, the wholesale distribution arm of Montu Australia. This strategic partnership will expand patient access to trusted, safe, and effective medical cannabis across Australia, while supporting healthcare professionals with educational resources. Leafio will serve as a wholesaler of Aurora's leading portfoli

    12/2/25 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Rubicon Organics Announces Appointment of Glen Ibbott as CFO

    VANCOUVER, British Columbia, Nov. 12, 2025 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV:ROMJ) (OTCQX:ROMJF) ("Rubicon Organics", "Rubicon", or the "Company"), a licensed producer focused on cultivating and selling organic certified and premium cannabis products, today announced the appointment of Glen Ibbott, a cannabis industry veteran and former Chief Financial Officer of Aurora Cannabis Inc. (TSX:ACB, NASDAQ:ACB) as its Chief Financial Officer and Corporate Secretary. "Over the past six months, Glen has demonstrated exceptional leadership, deep industry expertise, and a strong alignment with our values. His strategic insight and financial acumen have already made a significant impac

    11/12/25 8:00:00 PM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    $ACB
    $NEPT
    $PMD
    $YCBD
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/12/24 5:15:40 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13G/A filed by Psychemedics Corporation

    SC 13G/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/6/24 9:18:20 PM ET
    $PMD
    Medical Specialities
    Health Care

    Amendment: SEC Form SC 13D/A filed by Psychemedics Corporation

    SC 13D/A - PSYCHEMEDICS CORP (0000806517) (Subject)

    12/5/24 6:04:48 PM ET
    $PMD
    Medical Specialities
    Health Care

    $ACB
    $NEPT
    $PMD
    $YCBD
    Financials

    Live finance-specific insights

    View All

    Aurora Cannabis Announces Fiscal 2026 Third Quarter Results

    NASDAQ | TSX: ACB Expands YoY Total Net Revenue1 by 7% to $94.2 million, with Global Medical Cannabis Net Revenue1 Increasing by 12% to a Record $76.2 millionDelivers Adjusted EBITDA1 of $18.5 million and Adjusted Net Income1 of $7.2 millionGenerates Free Cash Flow1 of $15.5 million Maintains Strong Balance Sheet with $154.4 million of Cash2 and Short-Term Investments, and a Debt-Free Cannabis Business2EDMONTON, AB, Feb. 4, 2026 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third quarter 2026 period ending December 31, 2025.

    2/4/26 7:00:00 AM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    Aurora Cannabis to Host Third Quarter 2026 Investor Conference Call

    NASDAQ | TSX: ACB EDMONTON, AB, Jan. 21, 2026 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2026 on Wednesday, February 4, 2026 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the third quarter 2026 before the opening of markets that same day. Conference Call Details DATE: Wednesday, February 4, 2026 TIME: 8:00 a.m. Eastern Time |

    1/21/26 4:35:00 PM ET
    $ACB
    Medicinal Chemicals and Botanical Products
    Health Care

    cbdMD Reports Third Consecutive Year of Operating Improvement, Strengthens Balance Sheet, and Regains NYSE American Continued Listing Compliance

    CHARLOTTE, N.C., Dec. 19, 2025 /PRNewswire/ -- cbdMD, Inc. (NYSE:YCBD), one of the nation's leading and most highly trusted and recognized CBD companies, and operator of the leading CBD brands cbdMD and Paw CBD, along with hemp derived THC beverage line Herbal Oasis today announced our financial results for the full fiscal year ended September 30, 2025. For fiscal year 2025, cbdMD delivered its third consecutive year of operational and financial improvement, reflecting disciplined cost management, focused execution, and continued investment in quality and science. The Company

    12/19/25 4:10:00 PM ET
    $YCBD
    Package Goods/Cosmetics
    Consumer Discretionary